Published in FASEB J on February 09, 2010
Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine. J Bone Miner Res (2012) 1.14
Parathyroid hormone-related protein: an update. J Clin Endocrinol Metab (2012) 1.13
PTH receptor-1 signalling-mechanistic insights and therapeutic prospects. Nat Rev Endocrinol (2015) 0.98
Understanding and targeting osteoclastic activity in prostate cancer bone metastases. Curr Mol Med (2013) 0.87
Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocr Relat Cancer (2012) 0.86
Meta-analysis of gene-based genome-wide association studies of bone mineral density in Chinese and European subjects. Osteoporos Int (2011) 0.85
The physiological roles of vesicular GABA transporter during embryonic development: a study using knockout mice. Mol Brain (2010) 0.84
Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice. PLoS One (2014) 0.83
The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia. Br J Pharmacol (2011) 0.82
Duplicated zebrafish co-orthologs of parathyroid hormone-related peptide (PTHrP, Pthlh) play different roles in craniofacial skeletogenesis. J Endocrinol (2012) 0.81
Inhibitory function of parathyroid hormone-related protein on chondrocyte hypertrophy: the implication for articular cartilage repair. Arthritis Res Ther (2012) 0.80
3-dimensional imaging modalities for phenotyping genetically engineered mice. Vet Pathol (2011) 0.78
Deletion of the nuclear localization sequences and C-terminus of PTHrP impairs embryonic mammary development but also inhibits PTHrP production. PLoS One (2014) 0.77
Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates. Semin Oncol (2015) 0.75
Evolutionary well-conserved region in the signal peptide of parathyroid hormone-related protein is critical for its dual localization through the regulation of ER translocation. J Biochem (2015) 0.75
Homozygous truncating PTPRF mutation causes athelia. Hum Genet (2014) 0.75
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33
Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev (1994) 4.58
A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science (1987) 4.09
Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A (1987) 3.06
p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev (2005) 3.02
Mice lacking link protein develop dwarfism and craniofacial abnormalities. Nat Genet (1999) 2.58
Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci U S A (1996) 2.53
Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest (1987) 2.41
Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction. J Clin Endocrinol Metab (2001) 1.87
Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology (1996) 1.86
The p63 gene in EEC and other syndromes. J Med Genet (2002) 1.80
Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol (1995) 1.73
Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development (1998) 1.64
Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest (1999) 1.62
Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. EMBO J (2009) 1.54
Parathyroid hormone-related protein is required for tooth eruption. Proc Natl Acad Sci U S A (1998) 1.52
Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci U S A (1996) 1.42
The physiology of parathyroid hormone-related protein: an emerging role as a developmental factor. Annu Rev Physiol (1998) 1.28
SOX9-dependent and -independent transcriptional regulation of human cartilage link protein. J Biol Chem (2004) 1.27
Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha. J Biol Chem (1999) 1.24
Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest (2003) 1.18
PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development. Birth Defects Res C Embryo Today (2003) 1.08
Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein. Proc Natl Acad Sci U S A (2008) 1.08
Stimulation of ovine placental transport of calcium and magnesium by mid-molecule fragments of human parathyroid hormone-related protein. Exp Physiol (1990) 1.03
Overexpression of parathyroid hormone-related protein inhibits pancreatic beta-cell death in vivo and in vitro. Diabetes (2002) 1.00
Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia. Biochim Biophys Acta (2008) 0.97
Structural and physiologic characterization of the mid-region secretory species of parathyroid hormone-related protein. J Biol Chem (1996) 0.97
A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111]. Endocrinology (1991) 0.89
A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line. Endocrinology (1996) 0.89
PTHrP increases pancreatic beta-cell-specific functions in well-differentiated cells. Mol Cell Endocrinol (2001) 0.88
Molecular dissection of the importin beta1-recognized nuclear targeting signal of parathyroid hormone-related protein. Biochem Biophys Res Commun (2001) 0.88
Parathyroid hormone-related protein interacts with RNA. J Biol Chem (1999) 0.88
Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis. J Biol Chem (2001) 0.87
Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro. Calcif Tissue Int (2006) 0.86
The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells. Endocrinology (2001) 0.86
A carboxyl leucine-rich region of parathyroid hormone-related protein is critical for nuclear export. Endocrinology (2005) 0.85
The nucleolar targeting signal (NTS) of parathyroid hormone related protein mediates endocytosis and nucleolar translocation. J Bone Miner Res (1999) 0.84
C-terminal parathyroid hormone-related protein (PTHrP) (107-139) stimulates intracellular Ca(2+) through a receptor different from the type 1 PTH/PTHrP receptor in osteoblastic osteosarcoma UMR 106 cells. Endocrinology (2001) 0.83
Preliminary characterization of circulating amino- and carboxy-terminal fragments of parathyroid hormone-related peptide in humoral hypercalcemia of malignancy. J Clin Endocrinol Metab (1992) 0.81
Humoral hypercalcemia of malignancy: involvement of a novel hormone. Aust N Z J Med (1988) 0.80
Endogenous parathyroid hormone-related protein functions as a neuroprotective agent. Brain Res (2002) 0.80
Measurement of N- and C-terminal-region fragments of parathyroid hormone-related peptide in milk from lactating women and investigation of the relationship of their concentrations to calcium in milk. J Endocrinol (1997) 0.79
Parathyroid hormone-related protein (PTHrP) and Ca levels in the milk of lactating cows. J Vet Med Sci (2006) 0.78
Parathyroid hormone-related protein regulates intestinal calcium transport in sea bream (Sparus auratus). Am J Physiol Regul Integr Comp Physiol (2006) 0.78
Biologic activities of parathyroid hormone (1-34) and parathyroid hormone-related peptide (1-34) in isolated perfused rat femur. J Lab Clin Med (1992) 0.77
Effects of C-terminal parathyroid hormone-related peptide on osteoblasts. Miner Electrolyte Metab (1995) 0.77
A high abundance midregion species of parathyroid hormone-related protein: immunological and chromatographic characterization in plasma. J Clin Endocrinol Metab (1994) 0.76
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res (2002) 5.00
Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature (2009) 4.21
Cancer to bone: a fatal attraction. Nat Rev Cancer (2011) 4.08
Extra-embryonic function of Rb is essential for embryonic development and viability. Nature (2003) 3.92
Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res (2008) 3.41
Teriparatide and osseous regeneration in the oral cavity. N Engl J Med (2010) 3.08
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol (2003) 2.40
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res (2004) 2.36
Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era. J Clin Oncol (2003) 2.06
The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood (2008) 2.05
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology (2013) 2.02
Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology (2005) 1.85
Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res (2008) 1.78
In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice. Cancer Biol Ther (2003) 1.77
Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc Natl Acad Sci U S A (2003) 1.74
Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. J Periodontol (2007) 1.69
Stromal factors involved in prostate carcinoma metastasis to bone. Cancer (2003) 1.63
A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Res (2009) 1.61
Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells (2008) 1.58
Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. Cancer Res (2012) 1.58
An in vivo mouse model for human prostate cancer metastasis. Neoplasia (2008) 1.54
Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacol Ther (2008) 1.52
Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ (2002) 1.51
Mouse development with a single E2F activator. Nature (2008) 1.51
JunB as a downstream mediator of PTHrP actions in cementoblasts. J Bone Miner Res (2005) 1.47
Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res (2006) 1.45
Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology (2005) 1.44
A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res (2005) 1.40
Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. Bone (2007) 1.40
An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis. Cancer Res (2010) 1.39
The chicken frizzle feather is due to an α-keratin (KRT75) mutation that causes a defective rachis. PLoS Genet (2012) 1.36
Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells. J Bone Miner Res (2007) 1.35
Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem (2002) 1.28
Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. Bone (2005) 1.28
Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. Am J Pathol (2006) 1.26
Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem (2013) 1.25
Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev (2006) 1.25
Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Cancer Res (2004) 1.19
Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology (2002) 1.19
PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest. J Bone Miner Res (2005) 1.18
Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone. Proc Natl Acad Sci U S A (2014) 1.18
Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem (2004) 1.16
Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol Pathol (2013) 1.15
Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions. Int J Cancer (2008) 1.15
Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. Prostate (2010) 1.15
New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft. Prostate (2006) 1.15
The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials (2004) 1.14
Pre-clinical mouse models of human prostate cancer and their utility in drug discovery. Curr Protoc Pharmacol (2010) 1.12
Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Circ Cardiovasc Qual Outcomes (2011) 1.12
Allele-specific tumor spectrum in pten knockin mice. Proc Natl Acad Sci U S A (2010) 1.08
Detection and isolation of circulating tumor cells in urologic cancers: a review. Neoplasia (2004) 1.07
Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6. PLoS One (2010) 1.06
Mammary glands and feathers: comparing two skin appendages which help define novel classes during vertebrate evolution. Semin Cell Dev Biol (2007) 1.06
Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone. J Bone Miner Res (2008) 1.05
Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity. Chem Biol (2013) 1.05
Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Prostate (2008) 1.03
Antiresorptives and osteonecrosis of the jaw. J Evid Based Dent Pract (2012) 1.02
The impact of primary hyperparathyroidism on the oral cavity. J Clin Endocrinol Metab (2006) 1.01
An irradiation-altered bone marrow microenvironment impacts anabolic actions of PTH. Endocrinology (2011) 1.01
A novel canine lymphoma cell line: a translational and comparative model for lymphoma research. Leuk Res (2007) 1.01
Roles of bone marrow cells in skeletal metastases: no longer bystanders. Cancer Microenviron (2011) 1.01
The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J Biol Chem (2013) 1.00
Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro. Phys Med Biol (2007) 1.00
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts. Bone (2009) 0.99
RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. J Bone Miner Res (2004) 0.98
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Breast Cancer Res Treat (2007) 0.98
Hair-cycle-dependent expression of parathyroid hormone-related protein and its type I receptor: evidence for regulation at the anagen to catagen transition. J Invest Dermatol (2003) 0.98
Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. J Nutr (2005) 0.98
Effect of zoledronate on oral wound healing in rats. Clin Cancer Res (2010) 0.98
A honeybee's ability to learn, recognize, and discriminate odors depends upon odor sampling time and concentration. Behav Neurosci (2009) 0.97
Development, regeneration, and evolution of feathers. Annu Rev Anim Biosci (2014) 0.96
Ossicle and vossicle implant model systems. Methods Mol Biol (2008) 0.96
Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol (2006) 0.95
Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases. Clin Exp Metastasis (2007) 0.95
A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma. Cancer Res (2007) 0.95
Updates on osteonecrosis of the jaw. Curr Opin Support Palliat Care (2010) 0.94
Conversion of the nipple to hair-bearing epithelia by lowering bone morphogenetic protein pathway activity at the dermal-epidermal interface. Am J Pathol (2008) 0.94
Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression. J Biol Chem (2002) 0.94
Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment. Neoplasia (2012) 0.94
Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells. Stem Cells (2014) 0.93
The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice. PLoS One (2010) 0.93
Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes. J Endocrinol (2004) 0.92
Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells. Am J Pathol (2011) 0.91
Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter. Gynecol Oncol (2004) 0.91
Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Res (2010) 0.91